Oncology

Filter

Expanding Treatment Horizons: Advancements in Key mCRC Populations

August 2025

The following topics were covered during a symposium at the 2025 European Society for Medical Oncology Gastrointestinal Cancers (ESMO-GI)…

Live Webinar: Future Clinical Perspective of HRD Testing in Ovarian Cancer Samples Using NGS CGP | October 26th 5:00 PM - 6:00 PM BST

This webinar will present a short overview of when it is important to consider comprehensive genomic profiling (CGP) and its role in clinical research of solid tumors.

The Beginning of a New Era: Where Are We Going with Immunotherapies in Resectable NSCLC?

At the European Society for Thoracic Surgeons (ESTS) 2023 Conference Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt…

On-Demand Content - Past, Present, and Future of Personalized Care in Lung Cancer: HER2-Targeted and DLL3-Targeted Therapies in Focus

Access the exclusive video of Boehringer Ingelheim’s Industry Sponsored Symposium at the International Association for the Study of Lung…

Live Webinar: Translating Science into Patient Care: How are we treating muscle invasive bladder cancer patients today? October 10th 3:00 PM - 4:30 PM BST

This webinar will explore current treatment options for patients with muscle-invasive urothelial carcinoma.

The experience of Biosimilar Medicines in Oncology

This webinar takes a retrospective look at the use of monoclonal antibody biosimilars in the treatment of breast cancer.

EAU23 Highlights: Best treatments for localised disease

Dr Alberto Bossi. During EAU23 in Milan, Dr Alberto Bossi discusses the most recent advances in treatments for localised disease.

EMJ

EAU23 Highlights: Advanced hormone sensitive prostate cancer

Prof. Bernd Schmitz-Dräger. On the third day of EAU23 in Milan, Professor Bernd Schmitz-Dräger presents highlights from the congress in advanced hormone sensitive prostate cancer treatment.

EAU23 Highlights: Screening, early detection and advanced prostate cancer

Professor Peter Hammerer. On the final day of EAU23 in Milan, Professor Peter Hammerer provides updates from the congress on screening, early detection and advanced prostate cancer.

Loading posts...

« Previous 1 … 3 4 5 6 7 … 48 Next »